# Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial

> **NCT07207057** · PHASE3 · RECRUITING · sponsor: **University College, London** · enrollment: 1200 (estimated)

## Conditions studied

- Parkinsons Disease (PD)

## Interventions

- **DRUG:** Placebo
- **DRUG:** Telmisartan
- **DRUG:** Terazosin (Hytrin)

## Key facts

- **NCT ID:** NCT07207057
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-12
- **Primary completion:** 2031-05
- **Final completion:** 2031-07-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2025-10-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07207057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07207057, "Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07207057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*